News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,140 Results
Type
Article (39544)
Company Profile (254)
Press Release (655342)
Section
Business (204266)
Career Advice (2010)
Deals (35438)
Drug Delivery (93)
Drug Development (81065)
Employer Resources (170)
FDA (16153)
Job Trends (14852)
News (345278)
Policy (32506)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2545)
Accelerated approval (2)
Adcomms (21)
Allergies (78)
Alliances (49418)
ALS (80)
Alzheimer's disease (1330)
Antibody-drug conjugate (ADC) (102)
Approvals (16136)
Artificial intelligence (218)
Autoimmune disease (11)
Automation (14)
Bankruptcy (359)
Best Places to Work (11645)
BIOSECURE Act (18)
Biosimilars (95)
Biotechnology (182)
Bladder cancer (50)
Brain cancer (24)
Breast cancer (238)
Cancer (1835)
Cardiovascular disease (139)
Career advice (1673)
Career pathing (28)
CAR-T (133)
Cell therapy (380)
Cervical cancer (14)
Clinical research (65551)
Collaboration (723)
Compensation (418)
Complete response letters (18)
COVID-19 (2581)
CRISPR (34)
C-suite (189)
Cystic fibrosis (97)
Data (1773)
Decentralized trials (2)
Denatured (15)
Depression (36)
Diabetes (227)
Diagnostics (6310)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (107)
Drug pricing (94)
Drug shortages (25)
Duchenne muscular dystrophy (70)
Earnings (85875)
Editorial (30)
Employer branding (21)
Employer resources (146)
Events (111472)
Executive appointments (607)
FDA (17151)
Featured Employer (48)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (646)
Gene editing (91)
Generative AI (18)
Gene therapy (266)
GLP-1 (665)
Government (4370)
Grass and pollen (4)
Guidances (47)
Healthcare (18808)
Huntington's disease (22)
IgA nephropathy (20)
Immunology and inflammation (92)
Indications (24)
Infectious disease (2702)
Inflammatory bowel disease (129)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (72)
Interviews (312)
IPO (16491)
IRA (40)
Job creations (3637)
Job search strategy (1423)
Kidney cancer (9)
Labor market (30)
Layoffs (442)
Leadership (14)
Legal (7897)
Liver cancer (70)
Lung cancer (267)
Lymphoma (124)
Machine learning (2)
Management (58)
Manufacturing (253)
MASH (57)
Medical device (13295)
Medtech (13300)
Mergers & acquisitions (19375)
Metabolic disorders (594)
Multiple sclerosis (62)
NASH (16)
Neurodegenerative disease (71)
Neuropsychiatric disorders (23)
Neuroscience (1775)
NextGen: Class of 2025 (6521)
Non-profit (4477)
Northern California (2266)
Now hiring (36)
Obesity (328)
Opinion (197)
Ovarian cancer (62)
Pain (72)
Pancreatic cancer (72)
Parkinson's disease (124)
Partnered (17)
Patents (185)
Patient recruitment (85)
Peanut (45)
People (57040)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20425)
Phase II (28871)
Phase III (21499)
Pipeline (839)
Podcasts (41)
Policy (103)
Postmarket research (2564)
Preclinical (8615)
Press Release (64)
Prostate cancer (86)
Psychedelics (30)
Radiopharmaceuticals (243)
Rare diseases (345)
Real estate (5912)
Recruiting (65)
Regulatory (22054)
Reports (43)
Research institute (2316)
Resumes & cover letters (350)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (61)
Series A (114)
Series B (69)
Service/supplier (11)
Sickle cell disease (49)
Southern California (1956)
Special edition (14)
Sponsored (28)
Startups (3576)
State (2)
Stomach cancer (12)
Supply chain (58)
The Weekly (25)
United States (20006)
Vaccines (639)
Venture capitalists (35)
Webinars (12)
Weight loss (220)
Women's health (31)
Worklife (14)
Date
Today (115)
Last 7 days (604)
Last 30 days (2948)
Last 365 days (34000)
2025 (6429)
2024 (35251)
2023 (40104)
2022 (51230)
2021 (55762)
2020 (54123)
2019 (46565)
2018 (35041)
2017 (32144)
2016 (31522)
2015 (37590)
2014 (31361)
2013 (26382)
2012 (28585)
2011 (29284)
2010 (27353)
Location
Africa (717)
Alabama (48)
Alaska (7)
Arizona (215)
Arkansas (12)
Asia (37675)
Australia (6170)
California (5192)
Canada (1800)
China (424)
Colorado (238)
Connecticut (250)
Delaware (119)
Europe (80758)
Florida (771)
Georgia (181)
Idaho (57)
Illinois (468)
India (22)
Indiana (281)
Iowa (7)
Japan (130)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (799)
Massachusetts (3929)
Michigan (205)
Minnesota (355)
Mississippi (2)
Missouri (73)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (62)
New Jersey (1477)
New Mexico (28)
New York (1485)
North Carolina (885)
North Dakota (7)
Northern California (2266)
Ohio (181)
Oklahoma (13)
Oregon (33)
Pennsylvania (1191)
Puerto Rico (7)
Rhode Island (24)
South America (1093)
South Carolina (16)
South Dakota (1)
Southern California (1956)
Tennessee (87)
Texas (767)
Utah (160)
Virginia (121)
Washington D.C. (56)
Washington State (495)
West Virginia (3)
Wisconsin (47)
695,140 Results for "sillajen biotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
SillaJen Submits CSR to the US FDA for REN026 Study in Patients with RCC
SillaJen, Inc. (KOSDAQ: 215600) has submitted CSR to the US FDA on 06 Feb 2024 for REN026, a phase 1b/2a dose escalation and safety/efficacy evaluation study of Pexa-Vec in combination with cemiplimab in patients with metastatic or unresectable renal cell carcinoma (RCC).
March 27, 2024
·
5 min read
Press Releases
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
February 12, 2025
·
6 min read
Press Releases
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 7, 2025
February 9, 2025
·
1 min read
Business
Mid-Atlantic BioTherapeutics, Inc. and SMITM Capital Markets Ltd enter into a significant financing agreement
SMITM CAPITAL MARKETS LTD, has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT), a clinical-stage ready US biopharmaceutical company.
June 19, 2024
·
4 min read
Press Releases
Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq
October 18, 2024
·
4 min read
Press Releases
BioCardia Announces Japanese Patent for Helix™ Biotherapeutic Delivery System
March 10, 2025
·
4 min read
Press Releases
Bolt Biotherapeutics to Participate in Upcoming March 2025 Conferences
February 26, 2025
·
1 min read
Press Releases
Chrysalis BioTherapeutics, Inc. Announces Collaboration with NIAID to Evaluate Chrysalin® for the Treatment of Cutaneous Radiation Injury
November 18, 2024
·
2 min read
Deals
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering
Calidi Biotherapeutics, Inc. today announced the pricing of its “reasonable best efforts” public offering of 15,197,500 shares of common stock (or pre-funded warrants in lieu thereof) and accompanying Series A Common Warrants.
April 16, 2024
·
5 min read
Press Releases
Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
February 21, 2025
·
3 min read
1 of 69,514
Next
